CM Life Sciences, Inc. Contracts & Agreements
80 Contracts & Agreements
- Business Finance (30 contracts)
- Business Operations (2)
- Human Resources (19)
- Mergers & Acquisitions (1)
- Uncategorized (28)
- Sales Agreement, dated April 29, 2024, by and between GeneDx Holdings Corp. and TD Securities (USA) LLC (Filed With SEC on April 29, 2024)
- Description of Securities (Filed With SEC on February 23, 2024)
- Security Agreement, dated October 27, 2023, by and among the Company and Perceptive Credit Holdings IV, LP (Filed With SEC on October 30, 2023)
- Credit Agreement and Guaranty, dated October 27, 2023, by and among the Company and Perceptive Credit Holdings IV, LP (Filed With SEC on October 30, 2023)
- Warrant to Purchase Stock, dated October 27, 2023, by and among the Company and Perceptive Credit Holdings IV, LP (Filed With SEC on October 30, 2023)
- Form of Restricted Stock Unit Award Agreement under the 2023 Equity Inducement Plan (Filed With SEC on July 24, 2023)
- Form of Option Award Agreement under the 2023 Equity Inducement Plan (Filed With SEC on July 24, 2023)
- GeneDx Holdings Corp. 2023 Equity Inducement Plan (Filed With SEC on July 24, 2023)
- Letter Agreement, Amendment No. 2 to Sub-Sublease, dated as of March 20, 2023, by and between Icahn School of Medicine at Mount Sinai and the Company (Filed With SEC on May 9, 2023)
- GeneDx Holdings Corp. Amended and Restated 2021 Equity Incentive Plan (Filed With SEC on April 17, 2023)
- Amendment No. 1 to (Filed With SEC on April 14, 2023)
- 2022 Replacement Promissory Note (Filed With SEC on March 16, 2023)
- Amendment No. 1 to BioMe Biospecimen and Data Access Agreement, dated as of January 19, 2023, by and between Icahn School of Medicine at Mount Sinai and Sema4 OpCo, Inc (Filed With SEC on March 16, 2023)
- Employment Agreement of Kevin Feeley, dated January 14, 2022 (Filed With SEC on March 16, 2023)
- Description of Securities (Filed With SEC on March 16, 2023)
- Form of Subscription Agreement (Filed With SEC on January 30, 2023)
- Underwriting Agreement by and between GeneDx Holdings Corp. and Jefferies LLC, dated January 26, 2023 (Filed With SEC on January 30, 2023)
- Amendment No.1 to the Employment of Agreement of Kevin Feeley, dated August 25, 2022 (Filed With SEC on August 26, 2022)
- Separation Agreement and General Release with Isaac Ro, dated as of August 11, 2022 (Filed With SEC on August 15, 2022)
- Separation Agreement, dated as of (Filed With SEC on August 15, 2022)
- Consulting Agreement with Isaac Ro, dated as of June 14, 2022 (Filed With SEC on June 14, 2022)
- Amendment No.1 to the (Filed With SEC on June 14, 2022)
- Employment Agreement, dated as of January 14, 2022, as amended April 29, 2022, by and between Sema4 Holdings Corp. and Katherine Stueland (Filed With SEC on May 2, 2022)
- Transition Services Agreement, dated as of April 29, 2022, by and between GeneDx, Inc. and OPKO Health, Inc (Filed With SEC on May 2, 2022)
- Executive Chairman Agreement, date (Filed With SEC on March 14, 2022)
- Description of Securities (Filed With SEC on March 14, 2022)
- Separation Agreement with James Coffin dated as of January 25, 2022 (Filed With SEC on January 31, 2022)
- Loan and Security Agreement, dated as of November (Filed With SEC on November 15, 2021)
- Sub-Sublease, dated as of June 6, 2017, by and between Icahn School of Medicine at Mount Sinai and the Company, as amended July 31, 2019 (Filed With SEC on July 28, 2021)
- Form of RSU Agreement under the 2021 Incentive Award Plan (Filed With SEC on July 28, 2021)
- Form of Earn-Out RSU Agreement (Filed With SEC on July 28, 2021)
- 2021 Employee Stock Purchase Plan (Filed With SEC on July 28, 2021)
- Amended and Restated Employment of Agreement of Eric Schadt (Filed With SEC on July 28, 2021)
- Employment Agreement of Isaac Ro (Filed With SEC on July 28, 2021)
- Employment Agreement of Dan Clark (Filed With SEC on July 28, 2021)
- Employment Agreement of James Coffin (Filed With SEC on July 28, 2021)
- Employment Agreement of Anthony (Filed With SEC on July 28, 2021)
- Employment Agreement of Kareem (Filed With SEC on July 28, 2021)
- Employment Agreement of Karen White (Filed With SEC on July 28, 2021)
- Form of Stock Option Agreement under the 2021 Incentive Award Plan (Filed With SEC on July 28, 2021)
- 2021 Equity Incentive Award Plan (Filed With SEC on July 28, 2021)
- Form of Director and Officer Indemnification Agreement (Filed With SEC on July 28, 2021)
- Amended and Restated (Filed With SEC on July 28, 2021)
- Indemnity Agreement, dated September 1, 2020, by and between the Company and Eli Casdin (Filed With SEC on March 30, 2021)
- Description of the Companys securities (Filed With SEC on March 30, 2021)
- Indemnity Agreement, dated September 1, 2020, by and between the Company and Keith Meister (Filed With SEC on March 30, 2021)
- Indemnity Agreement, dated September 1, 2020, by and between the Company and Brian Emes (Filed With SEC on March 30, 2021)
- Indemnity Agreement, dated September 1, 2020, by and between the Company and Shaun Rodriguez (Filed With SEC on March 30, 2021)
- Indemnity Agreement, dated September 1, 2020, by and between the Company and Sean George (Filed With SEC on March 30, 2021)
- Indemnity Agreement, dated September 1, 2020, by and between the Company and Munib Islam (Filed With SEC on March 30, 2021)
- Indemnity Agreement, dated September 1, 2020, by and between the Company and Emily Leproust (Filed With SEC on March 30, 2021)
- Indemnity Agreement, dated September 1, 2020, by and between the Company and Nat Turner (Filed With SEC on March 30, 2021)
- Form of Amended and Restated Registration Rights Agreement (Filed With SEC on February 11, 2021)
- Forfeiture Agreement, dated as of February 9, 2021, by and between CMLS Holdings LLC and Mount Sinai Genomics, Inc. d/b/a Sema4 (Filed With SEC on February 11, 2021)
- Sponsor Support Agreement, dated as of February 9, 2021, by and among CMLS Holdings LLC, CM Life Sciences, Inc. and Mount Sinai Genomics, Inc. d/b/a Sema4 (Filed With SEC on February 11, 2021)
- Form of Shareholder Lock-Up Agreement (Filed With SEC on February 11, 2021)
- Form of Subscription Agreement (Filed With SEC on February 11, 2021)
- Agreement and Plan of Merger, dated as of February 9, 2021, by and among, CM Life Sciences, Inc., S-IV Sub, Inc., and Mount Sinai Genomics, Inc. d/b/a Sema4 (Filed With SEC on February 11, 2021)
- Forward Purchase Agreement, dated September 1, 2020, by and between the Company and Casdin Capital, LLC (Filed With SEC on September 4, 2020)
- Underwriting Agreement, dated September 1, 2020, by and between the Company and Jefferies LLC (Filed With SEC on September 4, 2020)
- Warrant Agreement, dated September 1, 2020, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent (Filed With SEC on September 4, 2020)
- Investment Management Trust Agreement, dated September 1, 2020, by and between the Company and Continental Stock Transfer & Trust Company, as trustee (Filed With SEC on September 4, 2020)
- Registration Rights Agreement, dated September 1, 2020, by and among the Company, CMLS Holdings LLC and the other holders party thereto (Filed With SEC on September 4, 2020)
- Letter Agreement, dated September 1, 2020, by and among the Company, its officers, its directors and CMLS Holdings LLC (Filed With SEC on September 4, 2020)
- Private Placement Warrants Purchase Agreement, dated September 1, 2020 by and among the Company, CMLS Holdings LLC and certain of the Companys directors named in Exhibit A thereto (Filed With SEC on September 4, 2020)
- Forward Purchase Agreement, dated September 1, 2020, by and between the Company and Corvex Management LP (Filed With SEC on September 4, 2020)
- Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on August 27, 2020)
- Specimen Unit Certificate (Filed With SEC on August 24, 2020)
- Specimen Class A Common Stock Certificate (Filed With SEC on August 24, 2020)
- Specimen Warrant Certificate (Filed With SEC on August 24, 2020)
- Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on August 24, 2020)
- Form of Letter Agreement among the Registrant, CMLS Holdings LLC and each of the executive officers and directors of the Registrant (Filed With SEC on August 24, 2020)
- Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on August 24, 2020)
- Form of Registration Rights Agreement among the Registrant, CMLS Holdings LLC and the Holders signatory thereto (Filed With SEC on August 24, 2020)
- Form of Private Placement Warrants Purchase Agreement between the Registrant, CMLS Holdings LLC and the individuals named in Exhibit A thereto (Filed With SEC on August 24, 2020)
- Form of Indemnity Agreement (Filed With SEC on August 24, 2020)
- Promissory Note issued to CMLS Holdings LLC (Filed With SEC on August 24, 2020)
- Securities Subscription Agreement between the Registrant and CMLS Holdings LLC (Filed With SEC on August 24, 2020)
- Form of Forward Purchase Agreement (Filed With SEC on August 24, 2020)
- Form of Underwriting Agreement (Filed With SEC on August 24, 2020)
